Long-Term Cardiac Safety and Tolerability of Fingolimod in Multiple Sclerosis: A Postmarketing Study
Paolicelli et al.
The Journal of Clinical Pharmacology; June 2015
Fingolimod is the first
The following content is accessible for members only, please sign in.
Loading…